usa-stockpile: massive press-release out !!!, page-3

"You really have to ask the question, why would GSK lift production to 190m doses if they didn't get some sort of indication of demand."


Yes PA, I think GSK were forced into it by Govenment demand and the Relenza was presold before it was produced, the CEO has effectively confirmed this.

Now the US is pushing for IV Relenza and GSK have been forced to respond to this.

GSK have cost Biota holders heaps and my wish is that they are not rewarded with the Lani deal.